126 related articles for article (PubMed ID: 32285607)
1. The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma.
Zhao R; Yu X; Feng Y; Wang J; Chen Y; Mao Y; Yin W; Zhang Z; Guo X; Ma S
Asia Pac J Clin Oncol; 2020 Aug; 16(4):266-272. PubMed ID: 32285607
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.
Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM
Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328
[TBL] [Abstract][Full Text] [Related]
3. Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.
Ding J; Wang C; Xiang J; Shen C; Hu C; Xu T; Lu X
Med Sci Monit; 2018 Sep; 24():6113-6118. PubMed ID: 30173244
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
5. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
Liu YT; Wang CW; Hong RL; Kuo SH
Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
[TBL] [Abstract][Full Text] [Related]
6. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma.
Zhao R; Yu X; Feng Y; Wang J; Mao Y; Yin W; Zhang Z; Guo X; Ma S
Jpn J Clin Oncol; 2018 Sep; 48(9):799-805. PubMed ID: 30060202
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
8. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
[TBL] [Abstract][Full Text] [Related]
9. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy analysis of adult sinonasal rhabdomyosarcoma].
Bai Y; Chen X; Yan Y; Zhang S; Zhou W; Fang J; Huang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(9):804-10. PubMed ID: 26281056
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
Eaton BR; McDonald MW; Kim S; Marcus RB; Sutter AL; Chen Z; Esiashvili N
Cancer; 2013 Apr; 119(8):1578-85. PubMed ID: 23280478
[TBL] [Abstract][Full Text] [Related]
12. Does surgery have a role in the treatment of local relapses of non-metastatic rhabdomyosarcoma?
De Corti F; Bisogno G; Dall'Igna P; Ferrari A; Buffa P; De Paoli A; Cecchetto G
Pediatr Blood Cancer; 2011 Dec; 57(7):1261-5. PubMed ID: 21826783
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
Mazzoleni S; Bisogno G; Garaventa A; Cecchetto G; Ferrari A; Sotti G; Donfrancesco A; Madon E; Casula L; Carli M;
Cancer; 2005 Jul; 104(1):183-90. PubMed ID: 15895378
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological characteristics, treatment outcome and prognostic factors in adult rhabdomyosarcoma: a monocentric retrospective study.
Saadi M; Letaief F; Gabsi A; Mokrani A; Meddeb K; Mezlini A
Pan Afr Med J; 2022; 41():246. PubMed ID: 35734321
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma.
Kim HJ; Koom WS; Cho J; Kim HS; Suh CO
Yonsei Med J; 2018 Nov; 59(9):1049-1056. PubMed ID: 30328319
[TBL] [Abstract][Full Text] [Related]
17. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy is an important factor to improve survival in pediatric patients with head and neck rhabdomyosarcoma by enhancing local control: a historical cohort study from a single center.
Wen Y; Huang D; Zhang W; Zhang Y; Hu H; Li J
BMC Pediatr; 2020 May; 20(1):265. PubMed ID: 32471472
[TBL] [Abstract][Full Text] [Related]
19. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
[TBL] [Abstract][Full Text] [Related]
20. Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.
Merks JH; De Salvo GL; Bergeron C; Bisogno G; De Paoli A; Ferrari A; Rey A; Oberlin O; Stevens MC; Kelsey A; Michalski J; Hawkins DS; Anderson JR
Ann Oncol; 2014 Jan; 25(1):231-6. PubMed ID: 24356633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
